Amneal Pharmaceuticals, Inc.

NYSE:AMRX Stock Report

Mkt Cap: US$718.0m

Amneal Pharmaceuticals Dividend

Dividend criteria checks 0/6

Amneal Pharmaceuticals, Inc. does not have a record of paying a dividend.

Key information

0%

Dividend yield

0%

Payout ratio

Industry average yield2.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareUS$0
Earnings per share-US$0.87
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Amneal Pharmaceuticals: Risk Still Persists

Jan 23

Amneal Pharma reaffirms 2022 guidance

Jan 10

Amneal joins hands with Orion to commercialize generic products in Europe and more countries

Jan 04

Here's Why Amneal Pharmaceuticals (NYSE:AMRX) Is Weighed Down By Its Debt Load

Dec 20
Here's Why Amneal Pharmaceuticals (NYSE:AMRX) Is Weighed Down By Its Debt Load

Amneal Pharmaceuticals large shareholder TPG cuts stake

Dec 14

FDA accepts Amneal Pharmaceuticals NDA for Parkinson's drug IPX203

Nov 11

Amneal Pharmaceuticals Q3 2022 Earnings Preview

Nov 03

Amneal Pharmaceuticals: A Small 'Thumbs Up'

Oct 28

Amneal Pharmaceuticals (NYSE:AMRX) Has A Somewhat Strained Balance Sheet

Sep 01
Amneal Pharmaceuticals (NYSE:AMRX) Has A Somewhat Strained Balance Sheet

Amneal Pharma submits NDA for novel formulation of Parkinson's disease treatment

Aug 31

Amneal Pharmaceuticals Q2 2022 Earnings Preview

Aug 04

Amneal Pharmaceuticals (NYSE:AMRX) Takes On Some Risk With Its Use Of Debt

Apr 16
Amneal Pharmaceuticals (NYSE:AMRX) Takes On Some Risk With Its Use Of Debt

Amneal Pharmaceuticals: Generics And Biosimilars Play Has Strong Upside Potential Under New / Old Management

Mar 30

Revisiting Amneal Pharmaceuticals After Its CEO Buys Shares

Dec 22

Amneal Pharmaceuticals (NYSE:AMRX) Has A Somewhat Strained Balance Sheet

Nov 23
Amneal Pharmaceuticals (NYSE:AMRX) Has A Somewhat Strained Balance Sheet

FDA accepts Amneal's Bevacizumab BLA for review, shares rise

Jun 17

Amneal Pharmaceuticals Q1 2021 Earnings Preview

May 06

Is Amneal Pharmaceuticals (NYSE:AMRX) A Risky Investment?

Apr 28
Is Amneal Pharmaceuticals (NYSE:AMRX) A Risky Investment?

What Percentage Of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Shares Do Insiders Own?

Feb 28
What Percentage Of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Shares Do Insiders Own?

A Closer Look At Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) Uninspiring ROE

Feb 05
A Closer Look At Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) Uninspiring ROE

Amneal to buy Kashiv Bio for upfront price of $100M

Jan 12

These 4 Measures Indicate That Amneal Pharmaceuticals (NYSE:AMRX) Is Using Debt Extensively

Jan 10
These 4 Measures Indicate That Amneal Pharmaceuticals (NYSE:AMRX) Is Using Debt Extensively

Are Amneal Pharmaceuticals's (NYSE:AMRX) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 06
Are Amneal Pharmaceuticals's (NYSE:AMRX) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Amneal Pharmaceuticals Q3 2020 Earnings Preview

Nov 05

Dividend Yield vs Market

Amneal Pharmaceuticals Dividend Yield vs Market
How does AMRX dividend yield compare to the market?
SegmentDividend Yield
Company (AMRX)0%
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.6%
Analyst forecast in 3 Years (AMRX)0%

Notable Dividend: Unable to evaluate AMRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

How stable has Amneal Pharmaceuticals's dividend per share been in the past?
MonthDividend Per Share (annual)Avg. Yield (%)
12/31/2024-1
12/31/2023-1
2/3/2023-0

Stable Dividend: Insufficient data to determine if AMRX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMRX's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: AMRX is not paying a notable dividend for the US market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AMRX has not reported any payouts.


Discover strong dividend paying companies